Applied genetic technologies corp (AGTC)
CashFlow / Yearly
Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12
Operating activities:
Net income (loss)

-2,006

-21,300

407

-

-

-

-

-

Net income (loss)

-

-

-

-1,381

-24,318

-15,908

-4,990

-1,924

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Share-based compensation expense

4,029

5,193

5,606

5,007

2,820

825

25

24

Share-based collaboration expense

-

-

-

636

-

-

-

-

Depreciation and amortization

1,273

1,175

912

567

376

334

285

262

Recovery of bad debts

-358

375

-

-

-

-

-

-

Investment discount accretion

790

-85

-402

-448

-158

-

-

-

Equity in net losses of an affiliate

-35

-20

-

-

-

-

-

-

Loss on disposal of property, plant and equipment

-

-1

-47

-

-

-

-

-

Loss on disposal of intangible assets

-

-126

-

-

-

-

-

-

Non-cash interest expense

-

-

-

-

-

-

-

23

Fair value adjustments

-

-

-

-

-

441

8

-204

Changes in operating assets and liabilities:
Grants receivable

-186

36

-780

-409

876

343

-41

-294

Prepaid and other assets

-1,635

1,903

240

1,562

-261

1,351

229

22

Deferred revenues

-28,392

-18,529

-

-

-

-

-

-

Accounts payable

327

-53

-333

140

228

156

674

-24

Increase (decrease) in deferred revenues

-

-

-38,230

63,664

-

-212

212

-

Accrued and other liabilities

604

2,326

-352

3,063

1,866

1,226

-10

-

Net cash used in operating activities

-23,457

-32,520

-31,001

-

-

-

-

-

Investing activities:
Increase (decrease) in accrued expenses

-

-

-

-

-

-

-

199

Net cash (used in) operating activities

-

-

-

70,991

-19,485

-11,928

-2,777

-1,372

Purchases of property and equipment

163

662

739

2,471

225

158

352

8

Purchases of and capitalized costs related to intangible assets

148

141

152

121

98

218

179

100

Investment in Bionic Sight

-

-

2,000

-

-

-

-

-

Maturities of investments

94,119

100,900

103,244

109,968

121,079

29,500

50

-

Purchases of investments

74,781

67,082

67,542

208,180

102,864

79,950

14,000

-

Net cash provided by investing activities

19,027

33,015

32,811

-

-

-

-

-

Financing activities:
Proceeds from the issuance of common stock, net of issuance costs

-

-

-

19,211

32,009

51,607

-

-

Proceeds from exercises of common stock options

-

-

-

283

148

194

-

-

Net cash provided by investing activities

-

-

-

-100,804

17,892

-50,826

-14,481

-108

Proceeds from exercise of common stock options

156

9

28

-

-

-

-

-

Taxes paid related to equity awards

36

-

-

-

-

-

-

-

Deferred offering costs

-

102

-

-

-

-

-

-

Payments made toward finance lease liability

52

43

-

-

-

-

-

-

Proceeds from exercise of convertible preferred stock warrants

-

-

-

-

-

1

-

-

Proceeds from issuance of convertible notes with detachable warrants

-

-

-

-

-

-

-

750

Proceeds from issuance of bank term note and warrants

-

-

-

-

-

-

507

-

Payment of bank term notes and capital lease

-

-

-

-

-

1

857

323

Net cash (used in) provided by financing activities

-

-

-

19,494

32,157

62,484

25,377

-

Net cash provided by (used in) financing activities

68

-136

28

-

-

-

-

427

Net increase (decrease) in cash and cash equivalents

-4,362

359

-

-

-

-

-

-

Supplemental information:
Net increase(decrease) in cash and cash equivalents

-

-

1,838

-10,319

30,564

-270

8,119

-1,053

Cash paid during the year for income taxes

-

617

887

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

39

38

Conversion of preferred stock warrants to common stock warrants

-

-

-

-

-

551

-

-

Capital lease obligation related to the purchase of equipment

-

240

-

-

-

-

-

7

Lease incentive obligation related to the purchase of leasehold improvements

-

2,588

-

-

-

-

-

-

Costs related to future offering costs included in accounts payable and accrued liabilities

-

163

-

-

-

-

-

-

Cost related to purchase of property and equipment included in accounts payable and accrued liabilities

124

-

-

-

-

-

-

-

Cost related to purchase of intellectual property included in accounts payable

59

-

-

-

-

-

-

-

Issuance of restricted stock for no consideration

36

49

-

-

-

-

-

-